• If you are wondering whether Agilent Technologies at around US$116.64 is offering fair value right now, starting with a clear view of what you are paying for is crucial.
• The stock has seen a 1.3% decline over the last 7 days, a 10.0% decline over the last 30 days and is down 15.4% year to date and 3.5% over the past year, which may have changed how the market is thinking about its growth prospects and risk.
• Over the past few months, Agilent has been in the news for its role in life sciences and diagnostics, as investors have been paying attention to how demand for its instruments and services is holding up. These headlines help frame whether recent share price weakness reflects short term sentiment or something more fundamental.
• On our valuation checks, Agilent scores 4 out of 6 for being potentially undervalued, giving it a valuation score of 4/6. This sets up a closer look at traditional methods like P/E, P/S and discounted cash flow, as well as a more complete way of thinking about value that we will come back to at the end.

Approach 1: Agilent Technologies Discounted Cash Flow (DCF) Analysis

A Discounted Cash Flow, or DCF, model estimates what a company might be worth today by projecting its future cash flows and then discounting those back to a single present value.

For Agilent Technologies, the model used is a 2 Stage Free Cash Flow to Equity approach. The latest twelve month Free Cash Flow is about $1.01b. Analysts provide forecasts for the next few years, and Simply Wall St extends those further. On these projections, Free Cash Flow is estimated at $1.12b in 2026 and $1.59b in 2027, with extrapolated figures reaching about $2.26b by 2035.

Bringing all those projected cash flows back to today, the DCF model suggests an estimated intrinsic value of around $125.16 per share. Compared with a current share price of about $116.64, this implies the shares are trading at roughly a 6.8% discount. This sits within a margin of error where small changes in assumptions can matter.

Result: ABOUT RIGHT

Agilent Technologies is fairly valued according to our Discounted Cash Flow (DCF), but this can change at a moment's notice. Track the value in your watchlist or portfolio and be alerted on when to act.

Approach 2: Agilent Technologies Price vs Earnings

For a profitable company like Agilent Technologies, the P/E ratio is a useful way to gauge what you are paying for each dollar of earnings. Investors usually accept a higher P/E when they expect stronger earnings growth or see the business as lower risk, while slower growth or higher uncertainty tend to justify a lower, more conservative multiple.

Agilent currently trades on a P/E of about 25.6x. That sits below both the Life Sciences industry average P/E of about 30.9x and a peer group average of about 30.1x. Simply Wall St also calculates a proprietary “Fair Ratio” for Agilent of about 23.2x, which is the P/E it might trade on given factors such as its earnings profile, industry, profit margins, market cap and risk characteristics.

This Fair Ratio can be more informative than a simple comparison with peers or the broad industry, because it is tailored to Agilent’s own fundamentals rather than assuming all Life Sciences companies deserve the same multiple. Set against the current P/E of 25.6x, the Fair Ratio of 23.2x indicates the shares are pricing in a somewhat higher multiple than this framework implies.

Result: OVERVALUED

P/E ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 20 top founder-led companies.

Upgrade Your Decision Making: Choose your Agilent Technologies Narrative

Earlier we mentioned that there is an even better way to understand valuation, and that is Narratives. This simply means you set out your story for Agilent Technologies, link it to your own forecast for revenue, earnings and margins, and arrive at a Fair Value that you can easily compare with today’s price on Simply Wall St’s Community page. On this page, millions of investors share views. For example, one investor might build a Narrative that supports a Fair Value close to the higher analyst target of US$165, while another might anchor nearer the lower US$120 figure. As new news, earnings or guidance come in, those Narratives and Fair Values update automatically to help you decide whether the current price still fits your story or if it is time to reconsider your position.

Do you think there's more to the story for Agilent Technologies? Head over to our Community to see what others are saying!

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.